Cited by 524Metabolism, Diabetes, and CancerMitochondrial Function and PathologyDiabetes Treatment and Management

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I

Open access

Brunmair, Barbara, Staniek, Katrin, Gras, Florian, Scharf, Nicole, Althaym, Aleksandra, Clara, Renate, Roden, Michael, Gnaiger, Erich, Nohl, Hans, Waldhäusl, Werner, Fürnsinn, Clemens·2004·Diabetes

DOI 10.2337/diabetes.53.4.1052

Open this paper in CoChat — free account Open PDF

Abstract

Metformin and thiazolidinediones (TZDs) are believed to exert their antidiabetic effects via different mechanisms. As evidence suggests that both impair cell respiration in vitro, this study compared their effects on mitochondrial functions. The activity of complex I of the respiratory chain, which is known to be affected by metformin, was measured in tissue homogenates that contained disrupted mitochondria. In homogenates of skeletal muscle, metformin and TZDs reduced the activity of complex I (30 mmol/l metformin, −15 ± 2%; 100 μmol/l rosiglitazone, −54 ± 7; and 100 μmol/l pioglitazone, −12 ± 4; P < 0.05 each). Inhibition of complex I was confirmed by reduced state 3 respiration of isolated mitochondria consuming glutamate + malate as substrates for complex I (30 mmol/l metformin, −77 ± 1%; 100 μmol/l rosiglitazone, −24 ± 4; and 100 μmol/l pioglitazone, −18 ± 5; P < 0.05 each), whereas respiration with succinate feeding into complex II was unaffected. In line with inhibition of complex I, 24-h exposure of isolated rat soleus muscle to metformin or TZDs reduced cell respiration and increased anaerobic glycolysis (glucose oxidation: 270 μmol/l metformin, −30 ± 9%; 9 μmol/l rosiglitazone, −25 ± 8; and 9 μmol/l pioglitazone, −45 ± 3; lactate release: 270 μmol/l metformin, +84 ± 12; 9 μmol/l rosiglitazone, +38 ± 6; and 9 μmol/l pioglitazone, +64 ± 11; P < 0.05 each). As both metformin and TZDs inhibit complex I activity and cell respiration in vitro, similar mitochondrial actions could contribute to their antidiabetic effects.

Integrity signals

Registry

Crossref · 10.2337/diabetes.53.4.1052

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,178
The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways
Fryer, L. G. D., Patel, A. P., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,035
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation
Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973
A Role for AMP-Activated Protein Kinase in Contraction- and Hypoxia-Regulated Glucose Transport in Skeletal Muscle
Mu, J., Brozinick, J. T., Valladares, O., Bucan, M., & Birnbaum, M. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00251-9 · Cited by 924
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806

Show all 39 references

Sorted by citations

Items 101–200 of 524

PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Lee, T., Bai, K., Lee, T.-I., Chao, T., Kao, Y., & Chen, Y. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-016-0309-5 · Cited by 116
Metformin Impairs Mitochondrial Function in Skeletal Muscle of Both Lean and Diabetic Rats in a Dose-Dependent Manner
Wessels, B., Čiapaitė, J., van den Broek, N. M. A., Nicolay, K., & Prompers, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100525 · Cited by 112
Cellular Responses to the Metal-Binding Properties of Metformin
Logie, L., Harthill, J. E., Patel, K., Bacon, S., Hamilton, D. L., Macrae, K., McDougall, G. J., Wang, H., Xue, L., Jiang, H., et al. (2012) · Diabetes · doi:10.2337/db11-0961 · Cited by 113
The Impact of Sperm Metabolism duringIn VitroStorage: The Stallion as a Model
Gibb, Z., & Aitken, R. J. (2016) · BioMed Research International · doi:10.1155/2016/9380609 · Cited by 108
mitoNEET as a novel drug target for mitochondrial dysfunction
Geldenhuys, W. J., Leeper, T. C., & Carroll, R. T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.001 · Cited by 108
Crystallographic Studies of Human MitoNEET
Hou, X., Liu, R., Ross, S. A., Smart, E. J., Zhu, H., & Gong, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700172200 · Cited by 107
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
Nerstedt, A., Johansson, A., Andersson, C. X., Cansby, E., Smith, U., & Mahlapuu, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1856-z · Cited by 106
Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Pereira, C., Moreira, A. C., Pereira, S. P., Machado, N. J., Carvalho, F. S., Sardão, V. A., & Oliveira, P. J. (2009) · Current Drug Safety · doi:10.2174/157488609787354440 · Cited by 107
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
Laskov, I., Drudi, L. M., Beauchamp, M.-C., Yasmeen, A., Ferenczy, A. S., Pollak, M., & Gotlieb, W. H. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.014 · Cited by 103
Obesity, metabolism and the microenvironment: Links to cancer
Makowski, L., Sundaram, S., & Johnson, A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.119606 · Cited by 106
Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice
Huang, S., Yu, R.-T., Gong, J., Feng, Y., Dai, Y.-L., Hu, F., Hu, Y., Tao, Y.-D., & Leng, Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2366-3 · Cited by 104
Metformin delays the manifestation of diabetes and vascular dysfunction in Goto–Kakizaki rats by reduction of mitochondrial oxidative stress
Rösen, P., & Wiernsperger, N. F. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.623 · Cited by 102
L-lactic acidosis: pathophysiology, classification, and causes; emphasis on biochemical and metabolic basis
Kamel, K. S., Oh, M. S., & Halperin, M. L. (2019) · Kidney International · doi:10.1016/j.kint.2019.08.023 · Cited by 128
AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity
Lee, J.-W., Choe, S. S., Jang, H., Kim, J., Jeong, H. W., Jo, H., Jeong, K.-H., Tadi, S., Park, M. G., Kwak, T. H., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m022897 · Cited by 102
Loss of Metabolic Plasticity Underlies Metformin Toxicity in Aged Caenorhabditis Elegans
Espada, L., Dakhovnik, A., Chaudhari, P., Martirosyan, A., Miek, L., Poliezhaieva, T., Schaub, Y., Nair, A., Döring, N., Rahnis, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00307-1 · Cited by 100
Evolutionarily adapted hormesis-inducing stressors can be a practical solution to mitigate harmful effects of chronic exposure to low dose chemical mixtures
Kim, S.-A., Lee, Y., Choi, J., Jacobs, D. R., & Lee, D. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.10.124 · Cited by 100
Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats
Kane, D. A., Anderson, E. J., Price, J. W., Woodlief, T. L., Lin, C.-T., Bikman, B. T., Cortright, R. N., & Neufer, P. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.022 · Cited by 99
AMPK regulation of mouse oocyte meiotic resumption in vitro
Chen, J., Hudson, E. R., Chi, M. M.-Y., Chang, A. S., Moley, K. H., Hardie, D. G., & Downs, S. M. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.11.039 · Cited by 99
The Pancreatic β-Cell: A Bioenergetic Perspective
Nicholls, D. G. (2016) · Physiological Reviews · doi:10.1152/physrev.00009.2016 · Cited by 100
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 102
Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus
Yu, X., Shao, X., Sun, H. B., Li, Y., Yang, J., Deng, Y., & Huang, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.047 · Cited by 100
Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics
Doliba, N. M., Qin, W., Najafi, H., Liu, C., Buettger, C. W., Sotiris, J., Collins, H. W., Li, C., Stanley, C. A., Wilson, D. F., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2011 · Cited by 96
Strategies to reduce late-stage drug attrition due to mitochondrial toxicity
Dykens, J. A., Marroquin, L. D., & Will, Y. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.161 · Cited by 95
Diabetes in Friedreich Ataxia
Cnop, M., Mulder, H., & Igoillo‐Esteve, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12216 · Cited by 99
Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might work
Fedson, D. S. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00090.x · Cited by 92
Drugs interfering with mitochondrial disorders
Finsterer, J., & Segall, L. (2009) · Drug and Chemical Toxicology · doi:10.3109/01480540903207076 · Cited by 92
Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism
Ota, S., Horigome, K., Ishii, T., Nakai, M., Hayashi, K., Kawamura, T., Kishino, A., Taiji, M., & Kimura, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.164 · Cited by 94
The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
Phielix, E., Szendroedi, J., & Roden, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.006 · Cited by 92
Self-citation
Mitochondrial off targets of drug therapy
Wallace, K. B. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.04.001 · Cited by 90
Peroxisome proliferator-activated receptor gamma (PPARγ): Is the genomic activity the only answer?
Luconi, M., Cantini, G., & Serio, M. (2009) · Steroids · doi:10.1016/j.steroids.2009.10.012 · Cited by 90
Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells
Soller, M., Dröse, S., Brandt, U., Brüne, B., & von Knethen, A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034371 · Cited by 89
Dissecting the role of AMP-activated protein kinase in human diseases
Li, J., Zhong, L., Wang, F., & Zhu, H. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.12.003 · Cited by 90
Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation
Forbes-Hernández, T. Y., Giampieri, F., Gasparrini, M., Afrin, S., Mazzoni, L., Cordero, M. D., Mezzetti, B., Quiles, J. L., & Battino, M. A. (2017) · Nutrients · doi:10.3390/nu9060621 · Cited by 91
Disrupting Mitochondrial–Nuclear Coevolution Affects OXPHOS Complex I Integrity and Impacts Human Health
Gershoni, M., Levin, L., Ovadia, O., Toiw, Y., Shani, N., Dadon, S., Barzilai, N., Bergman, A., Atzmon, G., Wainstein, J., et al. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu208 · Cited by 87
Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs—A mechanistic revisit to understand their mode of action
Gupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 92
Systemic effects of mitochondrial stress
Bar‐Ziv, R., Bolas, T., & Dillin, A. G. (2020) · EMBO Reports · doi:10.15252/embr.202050094 · Cited by 86
Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice
Kaneb, H., Sharp, P. S., Kondori, N. R., & Wells, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024189 · Cited by 87
Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury
Collino, M., Patel, N. S. A., & Thiemermann, C. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708090924 · Cited by 87
Metformin promotes isolated rat liver mitochondria impairment
Carvalho, C., Correia, S. C., Santos, M. S., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9614-3 · Cited by 88
Structural Insight into AMPK Regulation: ADP Comes into Play
Jin, X., Townley, R. A., & Shapiro, L. S. (2007) · Structure · doi:10.1016/j.str.2007.07.017 · Cited by 88
Cystic Fibrosis Transmembrane Regulator Inhibitors CFTRinh-172 and GlyH-101 Target Mitochondrial Functions, Independently of Chloride Channel Inhibition
Kelly, M., Trudel, S., Brouillard, F., Bouillaud, F., Colas, J., Nguyen‐Khoa, T., Ollero, M., Edelman, A., & Fritsch, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162032 · Cited by 86
Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: Potential utility in treatment of diabetes and heart disease
Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.008 · Cited by 88
Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication
Protti, A., Russo, R., Tagliabue, P. F., Vecchio, S., Singer, M., Rudiger, A., Foti, G., Rossi, A., Mistraletti, G., & Gattinoni, L. (2010) · Critical Care · doi:10.1186/cc8885 · Cited by 85
Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
Ahn, H. K., Lee, Y. H., & Koo, K. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228540 · Cited by 87
Biguanides: Species with versatile therapeutic applications
Kathuria, D., Raul, A. D., Wanjari, P. J., & Bharatam, P. V. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113378 · Cited by 87
Mitochondria and Energetic Depression in Cell Pathophysiology
Seppet, E. K., Puurand, M., Peetsalu, A., Gizatullina, Z. Z., Nguyen, H. P., Vielhaber, S., Wussling, M. H. P., Trumbeckaitė, S., Arandarčikaitė, O., Jerzembek, D., et al. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10052252 · Cited by 84
Impact of metformin on peak aerobic capacity
Braun, B., Eze, P. N., Stephens, B. R., Hagobian, T. A., Sharoff, C. G., Chipkin, S. R., & Goldstein, B. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-144 · Cited by 84
Metformin-Treated Patients With Type 2 Diabetes Have Normal Mitochondrial Complex I Respiration
Larsen, S., Rabøl, R., Hansen, C. N., Madsbad, S., Helge, J. W., & Dela, F. (2012) · Diabetologia · doi:10.1007/s00125-011-2340-0 · Cited by 81
Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system
Ismaiel, A. A., Espinosa‐Oliva, A. M., Santiago, M., García-Quintanilla, A., Oliva-Martín, M. J., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.004 · Cited by 81
FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes
Zhang, X., Yang, W., Wang, J., Meng, Y., Guan, Y., & Yang, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.001 · Cited by 81
Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation
Qiang, G., Yang, X., Shi, L., Zhang, H., Chen, B., Zhao, Y., Zu, M., Zhou, D., Guo, J., Yang, H., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430258 · Cited by 80
Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet
Chadwick, W., Roux, S., van de Venter, M., Louw, J., & Oelofsen, W. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.07.012 · Cited by 83
Emodin Regulates Glucose Utilization by Activating AMP-activated Protein Kinase*
Song, P., Kim, J. H., Ghim, J., Yoon, J. H., Lee, A., Kwon, Y., Hyun, H., Moon, H. Y., Choi, H., Berggren, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441477 · Cited by 80
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes
Grisouard, J., Timper, K., Radimerski, T., Frey, D. M., Peterli, R., Kola, B., Korbonits, M., Herrmann, P. C., Krähenbühl, S., Zulewski, H., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.021 · Cited by 82
Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
Yang, S. J., Choi, J. M., Chae, S. W., Kim, W. J., Park, S. E., Rhee, E., Lee, W., Oh, K. W., Park, S. W., Kim, S. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017057 · Cited by 77
Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids
Brunmair, B., Staniek, K., Dörig, J., Szöcs, Z., Stadlbauer, K., Marian, V., Gras, F., Anderwald, C. H., Nohl, H., Waldhäusl, W. K., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0357-6 · Cited by 79
Self-citation
Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N. A., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 78
Methyl succinate antagonises biguanide‐induced AMPK‐activation and death of pancreatic β‐cells through restoration of mitochondrial electron transfer
Hinke, S. A., Martens, G. A., Cai, Y., Finsi, J., Heimberg, H., PIPELEERS, D. G., & de Casteele, M. V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707189 · Cited by 76
Adenosine Monophosphate–Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation
Krishan, S., Richardson, D. R., & Sahni, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095810 · Cited by 80
The Mitochondrial Superoxide/Thioredoxin-2/Ask1 Signaling Pathway is Critically Involved in Troglitazone-Induced Cell Injury to Human Hepatocytes
Lim, P. L. K., Liu, J., Go, M., & Boelsterli, U. A. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm273 · Cited by 81
Iron chelators target both proliferating and quiescent cancer cells
Fryknäs, M., Zhang, X., Bremberg, U., Senkowski, W., Olofsson, M. H., Brandt, P., Persson, I., D’Arcy, P., Gullbo, J., Nygren, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38343 · Cited by 81
Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Andersen, J. L., Madsbad, S., Worm, D., Helge, J. W., & Dela, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2098-4 · Cited by 73
Three Peptides from Soy Glycinin Modulate Glucose Metabolism in Human Hepatic HepG2 Cells
Lammi, C., Zanoni, C., & Arnoldi, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126029 · Cited by 75
Hypothalamic AMPK as a Regulator of Energy Homeostasis
Huynh, M. K. Q., Kinyua, A. W., Yang, D. J., & Kim, K. W. (2016) · Neural Plasticity · doi:10.1155/2016/2754078 · Cited by 78
Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases
Cameron, R. B., Beeson, C., & Schnellmann, R. G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00669 · Cited by 77
Metformin Treatment Suppresses Melanoma Cell Growth and Motility Through Modulation of microRNA Expression
Tseng, H., Li, S., & Tsai, K. (2019) · Cancers · doi:10.3390/cancers11020209 · Cited by 72
Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition
Piel, S., Ehinger, J. K., Elmér, E., & Hansson, M. J. (2014) · Acta Physiologica · doi:10.1111/apha.12311 · Cited by 72
Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism
Gu, Y. J., Qi, C., Sun, X., Ma, X., Zhang, H., Hu, L., Yuan, J., & Yu, Q. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.002 · Cited by 71
Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice
Masciopinto, F., Pietro, N. D., Corona, C., Bomba, M., Pipino, C., Curcio, M., Castelnuovo, A. F. D., Ciavardelli, D., Silvestri, E., Canzoniero, L. M. T., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.189 · Cited by 71
Metformin overdose causes platelet mitochondrial dysfunction in humans
Protti, A., Lecchi, A., Fortunato, F., Artoni, A., Greppi, N., Vecchio, S., Fagiolari, G., Moggio, M. G., Comi, G. P., Mistraletti, G., et al. (2012) · Critical Care · doi:10.1186/cc11663 · Cited by 71
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., Tong, N., & Li, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181995 · Cited by 69
5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo
Hasenour, C. M., Ridley, D. E., Hughey, C. C., James, F. D., Donahue, E. P., Shearer, J., Viollet, B., Foretz, M., & Wasserman, D. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528232 · Cited by 76
Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function
Yaribeygi, H., Atkin, S. L., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27754 · Cited by 72
Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome
Harris, S. E., Maruthini, D., Tang, T., Balen, A. H., & Picton, H. M. (2010) · Human Reproduction · doi:10.1093/humrep/deq181 · Cited by 67
Regional Anatomic Differences in Skeletal Muscle Mitochondrial Respiration in Type 2 Diabetes and Obesity
Rabøl, R., Larsen, S., Højberg, P. V., Almdal, T., Boushel, R., Haugaard, S. B., Andersen, J. L., Madsbad, S., & Dela, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1844 · Cited by 68
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
Bahar, E., Han, S., Kim, J., & Yoon, H. (2022) · Cancers · doi:10.3390/cancers14061462 · Cited by 67
Neuroprotective Effects of Metformin Through the Modulation of Neuroinflammation and Oxidative Stress
Reed, S., Taka, E., Darling‐Reed, S., & Soliman, K. F. A. (2025) · Cells · doi:10.3390/cells14141064 · Cited by 76
Impaired Oocyte Quality Induced by Dehydroepiandrosterone Is Partially Rescued by Metformin Treatment
Huang, Y., Yu, Y., Gao, J., Li, R., Zhang, C., Zhao, H., Zhao, Y., & Qiao, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122370 · Cited by 67
Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators
Yu, L.-F., Li, Y., Su, M., Zhang, M., Zhang, W., Zhang, L.-N., Pang, T., Zhang, R., Liu, B., Li, J.-Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400028q · Cited by 66
Mitochondrially-targeted treatment strategies
Bozi, L. H. M., Campos, J. C., Zambelli, V. O., Ferreira, N. D., & Ferreira, J. C. B. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100836 · Cited by 67
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 71
Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice
Li, Y., Yu, L.-F., Zhang, L., Qiu, B., Su, M., Wu, F., Chen, D.-K., Pang, T., Gu, M., Zhang, W., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.006 · Cited by 66
Mitochondrial dynamics in exercise physiology
Tanaka, T., Nishimura, A., Nishiyama, K., Goto, T., Numaga‐Tomita, T., & Nishida, M. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02258-3 · Cited by 67
Metformin as an adjuvant in breast cancer treatment
Roshan, M. H. K., Shing, Y. K., & Pace, N. P. (2019) · SAGE Open Medicine · doi:10.1177/2050312119865114 · Cited by 63
Promotion of adiponectin multimerization by emodin: A novel AMPK activator with PPARγ‐agonist activity
Chen, Z., Zhang, L., Yi, J., Yang, Z., Zhang, Z., & Li, Z. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24232 · Cited by 64
Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs
Protti, A., Fortunato, F., Monti, M., Vecchio, S., Gatti, S., Comi, G. P., Giuseppe, R. D., & Gattinoni, L. (2012) · Critical Care · doi:10.1186/cc11332 · Cited by 64
Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
Ikhlas, S., & Ahmad, M. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.029 · Cited by 66
AMPK activators – potential therapeutics for metabolic and other diseases
Zhou, G., Sebhat, I. K., & Zhang, B. B. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01967.x · Cited by 63
Metformin-induced anticancer activities: recent insights
Safe, S. H., Nair, V., & Karki, K. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0271 · Cited by 62
Hepatic Overexpression of ATP Synthase β Subunit Activates PI3K/Akt Pathway to Ameliorate Hyperglycemia of Diabetic Mice
Wang, C., Chen, Z., Li, S., Zhang, Y., Shi, J., Li, J., Chi, Y., Miao, Y., Guan, Y., & Yang, J. (2013) · Diabetes · doi:10.2337/db13-1096 · Cited by 63
Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease
Rafeh, R. W., Viveiros, A., Oudit, G. Y., & EL‐Yazbi, A. F. (2020) · Clinical Science · doi:10.1042/cs20190227 · Cited by 63
Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes
Fazakerley, D. J., Naghiloo, S., Chaudhuri, R., Koumanov, F., Burchfield, J. G., Thomas, K. C., Krycer, J. R., Prior, M. J., Parker, B. L., Murrow, B. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657361 · Cited by 60
Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
Rana, S., Blowers, E. C., & Natarajan, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401994c · Cited by 63
Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases
Colca, J. R., Tanis, S. P., McDonald, W. G., & Kletzien, R. F. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.839659 · Cited by 61
Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain
García‐Ruíz, I., Solís‐Muñoz, P., Fernández-Moreira, D., Muñoz‐Yagüe, T., & Solis-Herruzo, J. A. (2013) · BMC Biology · doi:10.1186/1741-7007-11-88 · Cited by 64
Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?
Speirs, C., Williams, J. J. L., Riches‐Suman, K., Salt, I. P., & Palmer, T. M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.001 · Cited by 61
Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling
Osman, I., & Segar, L. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.026 · Cited by 58
Pharmacology of metformin – An update
Glossmann, H. H., & Lutz, O. M. D. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172782 · Cited by 62
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Galal, M. A., Al-Rimawi, M., Hajeer, A., Dahman, H., Alouch, S. S., & Aljada, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074083 · Cited by 73
Rosiglitazone Causes Cardiotoxicity via Peroxisome Proliferator-Activated Receptor γ-Independent Mitochondrial Oxidative Stress in Mouse Hearts
He, H., Tao, H., Xiong, H., Duan, S. Z., McGowan, F. X. J., Mortensen, R. M., & Balschi, J. A. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu015 · Cited by 59

Authors: Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., & Fürnsinn, C.
Affiliations: University of Vienna (AT)
University of Veterinary Medicine Vienna (AT)
Universität Innsbruck (AT)
Department of Medicine III, Division of Endocrinology & Metabolism, University of Vienna, Vienna, Austria
ORCID: Brunmair, Barbara
Roden, Michael
Gnaiger, Erich
Venue: Diabetes
Publisher: American Diabetes Association
Published: 2004-04-01
Volume: 53
Issue: 4
Pages: 1052-1059
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/diabetes.53.4.1052
OpenAlex: W2403578638
Cited by: 521
References: 39
Citations by year: 2026: 6 · 2025: 9 · 2024: 15 · 2023: 10 · 2022: 14 · 2021: 15 · 2020: 33 · 2019: 25 · 2018: 16 · 2017: 27 · 2016: 37 · 2015: 30 · 2014: 40 · 2013: 33 · 2012: 29
FWCI: 7.64
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Diabetes (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer
Austrian Science Fund
Universität Wien
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: thiazolidinediones, metformin, mitochondrial complex I, mitochondrial respiration, rosiglitazone, pioglitazone, skeletal muscle, anaerobic glycolysis, glucose oxidation, lactate release, antidiabetic mechanism, type 2 diabetes
MeSH terms: Rosiglitazone, Pioglitazone, Animals, Energy Metabolism, Hypoglycemic Agents, Male, Metformin, Mitochondria, Oxygen Consumption, Potassium Chloride, Rotenone, Rats, Sprague-Dawley, Muscle, Skeletal, Electron Transport Complex I, Thiazolidinediones, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks